Abstract:Macrocyclic peptides, an intriguing class of molecules, embody promising frameworks for the development of chemical probes and prospective therapeutic agents. However, the lack of an established wide-substrate scope synthesis methodology has made it challenging to achieve both efficiency and selectivity simultaneously. P450-catalyzed ribosomal synthesized and post-translational modification peptides (RiPPs) are a new family of macrocyclic peptides with typical biaryl crosslinks. In this study, we report the discovery of a RiPP-modified P450 macrocyclase, GpeC, which natively catalyzes the biaryl C(sp2)-C(sp2) crosslink of tryptophan-tyrosine in a tetrapeptide module. Unlike most previously documented P450-RiPPs that possess a substantial leader peptide region, hindering biocatalytic applications, our P450 GpeC exhibits catalytic potential with leaderless precursor peptides and a wide substrate tolerance, highlighting its adaptability and potential for creating diverse macrocyclic structures. The crystal structure of GpeC, combined with in silico calculations and site-directed mutagenesis, provides strong evidence for the extreme flexibility of intra-cyclic amino acids within the biaryl-cyclized tetrapeptide. This flexibility enables the substitution of any of the other 19 amino acids, indicating that GpeC is a robust and adaptable catalyst for biaryl cyclization, providing a valuable resource for the biocatalytic synthesis of complex macrocyclic compounds.

Backbone‐Enabled Directional Peptide Macrocyclization Through Late‐Stage Palladium‐Catalyzed Δ‐c(sp2)−h Olefination

Backbone-Enabled Peptide Macrocyclization Through Late-Stage Palladium-Catalyzed C-H Activation

Peptide Macrocyclization Through Palladium-Catalyzed Late-Stage C-H Activation.

Macrocyclization of peptidoarylacetamides with self-assembly properties through late-stage palladium-catalyzed C(sp 2 )▬H olefination.

Macrocyclization of Biaryl-Bridged Peptides Through Late-Stage Palladium-Catalyzed C(sp(2))-H Arylation

Late‐Stage Peptide Macrocyclization by Palladium‐Catalyzed Site‐Selective C−H Olefination of Tryptophan

Macrocyclization of Bioactive Peptides with Internal Thiazole Motifs Via Palladium-Catalyzed C–H Olefination

A general strategy for synthesis of cyclophane-braced peptide macrocycles via palladium-catalysed intramolecular sp3 C−H arylation

Synthesis of Cyclophane-Braced Peptide Macrocycles via Palladium-Catalyzed Intramolecular C(sp 3 )–H Arylation of N -Methyl Alanine at C-Termini

Peptide-guided Functionalization and Macrocyclization of Bioactive Peptidosulfonamides by Pd(II)-catalyzed Late-Stage C–H Activation

Late-Stage Macrocyclization of Bioactive Peptides with Internal Oxazole Motifs via Palladium-Catalyzed C-H Olefination

Construction of Cyclophane-Braced Peptide Macrocycles via Palladium-Catalyzed Picolinamide-Directed Intramolecular C(sp 2 )–H Arylation

Diastereoselective Anomeric C(sp3)‐H Cyclization Towards the Design of New Cyclophane‐Braced Glycopeptides

P III ‐directed Late‐Stage Ligation and Macrocyclization of Peptides with Olefins by Rhodium Catalysis

Diastereoselective Anomeric C(sp3)-H Cyclization Towards the Design of New Generations of Cyclophane-Braced Glycopeptides

Crafting Unnatural Peptide Macrocycles via Rh(III)-Catalyzed Carboamidation

Peptide Macrocyclization via Cu-catalyzed 1,3-Dipolar Cycloaddition of Azomethine Ylides

Construction of Peptide Macrocycles via Palladium-Catalyzed Multiple S-Arylation: An Effective Strategy to Expand the Structural Diversity of Cross-Linkers

Late-Stage Functionalization and Diversification of Peptides by Internal Thiazole-Enabled Palladium-Catalyzed C(sp3)–H Arylation

P450-Catalyzed Biaryl Macrocyclization of Leaderless Ribosomal Peptides

Transition-Metal-Catalyzed C–C Bond Macrocyclization via Intramolecular C–H Bond Activation